Lab-on-a-Chip Market
The global Lab-on-a-Chip (LoC) market size reached USD 6.78 billion in 2024 and is expected to reach USD 14.66 billion by 2032, with a CAGR of 10.12% during the forecast period (2025-2032). This robust growth is driven by the growing demand for rapid, portable and cost-effective diagnostic tools in healthcare and research, the increasing prevalence of chronic and infectious diseases, advances in microfluidics and AI integration for point-of-care testing, the shift to personalized medicine and the increasing applications in drug discovery and genomics.
Get a free sample PDF of this report (get higher priority for business email ID):-
https://www.datamintelligence.com/download-sample/lab-on-a-chip-market?sindhuri
North America: Key Industry Developments (Largest Region)
✅ November 2025: Thermo Fisher Scientific expanded its microfluidic platforms with AI-enhanced analytics for real-time biomarker detection, targeting high-throughput clinical diagnostics at major US research centers.
✅ October 2025: The US National Science Foundation announced additional funding for organ-on-chip projects, supporting advances in personalized medicine and reducing animal testing in pharmaceutical development.
✅ September 2025: Danaher Corporation (via Cepheid) launched next-generation portable LoC devices for infectious disease testing integrated with rapid molecular diagnostics for point-of-care deployment in hospitals.
Asia Pacific: Key Industry Developments (Fastest Growing Region)
✅ November 2025: Agilent Technologies introduces advanced LoC solutions aligned with high-density genomics in emerging markets, with a focus on compliance with regional healthcare standards in China and India.
✅ October 2025: The Indian government expanded Digital India initiatives for affordable POC diagnostics, subsidizing LoC adoption in rural clinics to address the rising chronic disease burden.
✅ September 2025: Illumina partnered with local biotech companies in Asia to develop cost-effective LoC arrays for population-scale genetic screening, accelerating deployment in fast-growing markets such as Singapore and Japan.
Most important mergers and acquisitions (2025):
✅ Danaher Strengthens Diagnostics Portfolio: In mid-2025, Danaher acquired specialized microfluidic assets to enhance its Cepheid LoC platforms for faster pathogen detection.
✅ Thermo Fisher Scientific advances AI integration: In early 2025, strategic partnerships and acquisitions focused on AI-driven LoC analytics, aimed at accelerating drug discovery.
Buy this report before the end of the year and benefit from an exclusive 30% discount:
https://www.datamintelligence.com/buy-now-page?report=lab-on-a-chip-market?sindhuri
(Buy 2 or more reports and receive a 50% discount)
Market Segmentation Analysis:
-By product: Reagents and consumables lead with dominant share
The Reagents & Consumables segment has the largest market share, driven by recurring demand for diagnostics and research applications. This segment benefits from the need for high-volume disposable components in microfluidic testing.
The Instrument segment is the fastest growing segment, driven by technological advances in integrated systems for automation and precision.
-By technology: microfluidics controls most of it
Microfluidics remains the leading technology, essential for precise fluid handling and miniaturization in diagnostic devices.
However, integration with AI and optical technologies is expected to drive the fastest growth, enabling advanced data analytics and multi-modal sensing.
-By application: Clinical diagnostics and genomics Top with strong demand
Clinical diagnostics remains a fundamental application, crucial for rapid disease detection, POC testing and biomarker analysis.
Genomics and Drug Discovery are rapidly growing areas, driven by personalized medicine and high-throughput screening needs.
Growth factors:
Rising demand for point-of-care and rapid diagnostics: The need for portable, immediate testing in clinics, at home and in resource-constrained settings makes LoC essential for managing chronic and infectious diseases.
Advances in microfluidics and AI integration: Innovations enable precise, automated analysis of complex biological data, accelerating diagnostics and research.
Personalized medicine and genomics boom: LoC supports accurate identification of biomarkers and tailored treatments, especially in oncology and rare diseases.
Increasing prevalence of chronic diseases: The global increase in conditions requiring frequent monitoring is driving the adoption of efficient, low-cost LoC solutions.
Efficiency needs in drug discovery: Miniaturized platforms reduce costs and time in high-throughput screening and toxicology testing.
Talk to our analyst and get customized report as per your requirements:
https://www.datamintelligence.com/customize/lab-on-a-chip-market?sindhuri
Regional insights:
North America dominates the global LoC market and accounts for the largest share (about 43% in 2024). This leadership comes from an advanced healthcare infrastructure, high investments in research and development, the presence of key players and early adoption in diagnostics and biotechnology.
Asia Pacific is the fastest growing region, driven by the rapid expansion of healthcare, government investments in biotechnology (e.g. financing China and India’s Digital India), rising disease burden and demand for affordable POC solutions.
Main players:
Thermo Fisher Scientific | Illumina | Danaher Corporation | Merck KGaA | Abbott Laboratories | QIAGEN | Agilent Technologies | Standard BioTools | Revvity | Bio-Rad Labs
Key Highlights (Top 5 Key Players) for Lab-on-a-Chip Market:
1. Thermo Fisher Scientific maintains its leadership with its extensive portfolio of microfluidic instruments and reagents, deeply integrated for genomics, diagnostics and drug discovery applications.
2. Illumina dominates LoC platforms for high-throughput sequencing, providing unparalleled precision in genetic analysis and supporting large-scale population studies.
3. Danaher (Cepheid) excels in rapid molecular diagnostics, delivering portable LoC solutions for infectious disease detection with superior speed and accuracy.
4. Agilent Technologies uses advanced analytics and microfluidics for research and clinical applications, appealing to laboratories that need versatile, powerful tools.
5. Bio-Rad Laboratories innovates in the field of digital droplet PCR and microfluidics and positions itself strongly in genomics and precision diagnostics for complex tests.
Unlock 360° market intelligence with DataM subscription services: https://www.datamintelligence.com/reports-subscription
Support your decisions with real-time competitor tracking, strategic forecasting, and global investment insights, all in one place.
✅ Competitive landscape
✅ Sustainability impact analysis
✅ KOL / Stakeholder Insights
✅ Unmet needs and positioning, pricing and market entry snapshots
✅ Analysis of market volatility and emerging risks
✅ Quarterly sector report updated
✅ Live market and price trends
✅ Import-export data monitoring
View our subscription dashboard: https://www.youtube.com/watch?sindhuri
Contact us –
Company name: DataM Intelligence
Contact person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About us –
DataM Intelligence is a market research and consultancy firm that provides end-to-end business solutions to organizations, from research to advice. At DataM Intelligence, we leverage our key trademark trends, insights and developments to deliver fast and astute solutions to customers like you. We include a wide range of syndicated reports and custom reports with a robust methodology.
Our research database contains countless statistics and in-depth analyzes on a wide range of 6300+ reports in 40+ domains, creating business solutions for 200+ companies in 50+ countries; addressing key business research needs that impact the growth trajectory of our vast customer base.
This release was published on openPR.